Publications

Antimicrobial agents and chemotherapy

 Ulferts R, de Boer SM, van der Linden L, Bauer L, Lyoo HR, Maté MJ, Lichière J, Canard B, Lelieveld D, Omta W, Egan D, Coutard B, van Kuppeveld FJM
 Antimicrobial agents and chemotherapy - vol. 60 2627-38 (2016)

Enteroviruses (EVs) represent many important pathogens of humans. Unfortunately, no antiviral compounds currently exist to treat infections with these viruses. We screened the Prestwick Chemical Library, a library of approved drugs, for inhibitors of coxsackievirus B3, identified pirlindole as a potent novel inhibitor, and confirmed the inhibitory action of dibucaine, zuclopenthixol, fluoxetine, and formoterol. Upon […]

International journal of antimicrobial agents

 Samantaray S, Correia JN, Garelnabi M, Voelz K, May RC, Hall RA
 International journal of antimicrobial agents - vol. 48 69-77 (2016)

The fungal pathogen Cryptococcus neoformans poses a major threat to immunocompromised patients and is a leading killer of human immunodeficiency virus (HIV)-infected patients worldwide. Cryptococci are known to manipulate host macrophages and can either remain latent or proliferate intracellularly within the host phagocyte, a favourable niche that also renders them relatively insensitive to antifungal agents. […]

Journal of biomolecular screening

 Iglesias A, Lage S, Cadavid MI, Loza MI, Brea J
 Journal of biomolecular screening (2016)

G protein-coupled receptors (GPCRs) exist as collections of conformations in equilibrium, and the efficacy of drugs has been proposed to be associated with their absolute and relative affinities for these different conformations. The serotonin 2A(5-HT2A) receptor regulates multiple physiological functions, is involved in the pathophysiology of schizophrenia, and serves as an important target of atypical […]

Biochemical Pharmacology

 Prado S, Beltrán M, Coiras M, Bedoya LM, Alcamí J, Gallego J
 Biochemical Pharmacology - vol. 107 14-28 (2016)

New antiretroviral agents with alternative mechanisms are needed to complement the combination therapies used to treat HIV-1 infections. Here we report the identification of bioavailable molecules that interfere with the gene expression processes of HIV-1. The compounds were detected by screening a small library of FDA-approved drugs with an assay based on measuring the displacement […]

All our screening libraries

Partners